Immix Biopharma, Inc.
IMMX
$10.97
$0.050.46%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -72.60% | -67.41% | -36.21% | -7.64% | -21.58% |
| Total Depreciation and Amortization | 136.28% | 189.38% | 215.86% | 308.29% | 291.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.16% | -25.92% | -16.82% | -19.85% | -9.98% |
| Change in Net Operating Assets | -121.76% | -94.37% | -31.90% | 124.59% | 682.90% |
| Cash from Operations | -207.81% | -157.54% | -63.96% | 8.99% | 15.76% |
| Capital Expenditure | 39.31% | 26.05% | 37.77% | -57.23% | -115.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -839.38% | -1,166.23% | -512.53% | -57.23% | -115.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 23,470.77% | -- | 574.19% | -28.12% | -95.84% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 23,458.43% | -- | 573.33% | -29.13% | -95.83% |
| Foreign Exchange rate Adjustments | -160.00% | 16.67% | 205.56% | -118.18% | 88.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,833.39% | 572.67% | 44,203.66% | -3,565.93% | -208.97% |